These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29608391)

  • 21.
    Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
    Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMB-XMA0038, a new inhibitor targeting aspartate-semialdehyde dehydrogenase of
    Wang X; Yang R; Liu S; Guan Y; Xiao C; Li C; Meng J; Pang Y; Liu Y
    Emerg Microbes Infect; 2021 Dec; 10(1):2291-2299. PubMed ID: 34779708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IPC synthase as a useful target for antifungal drugs.
    Sugimoto Y; Sakoh H; Yamada K
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):311-22. PubMed ID: 15578972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoemulsion as an Effective Treatment against Human-Pathogenic Fungi.
    Garcia A; Fan YY; Vellanki S; Huh EY; Vanegas D; Wang SH; Lee SC
    mSphere; 2019 Dec; 4(6):. PubMed ID: 31852807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.
    Georgopapadakou NH
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1117-25. PubMed ID: 12150705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris.
    Iyer KR; Whitesell L; Porco JA; Henkel T; Brown LE; Robbins N; Cowen LE
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dectin-2-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
    Ambati S; Ellis EC; Lin J; Lin X; Lewis ZA; Meagher RB
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31666315
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacoinformatics analysis to identify inhibitors of Mtb-ASADH.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2016; 34(1):1-14. PubMed ID: 25565373
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Chitty JL; Blake KL; Blundell RD; Koh YQAE; Thompson M; Robertson AAB; Butler MS; Cooper MA; Kappler U; Williams SJ; Kobe B; Fraser JA
    J Biol Chem; 2017 Jul; 292(28):11829-11839. PubMed ID: 28559277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure of a redundant enzyme: a second isoform of aspartate beta-semialdehyde dehydrogenase in Vibrio cholerae.
    Viola RE; Liu X; Ohren JF; Faehnle CR
    Acta Crystallogr D Biol Crystallogr; 2008 Mar; 64(Pt 3):321-30. PubMed ID: 18323627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens.
    Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1391-2. PubMed ID: 2802565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.
    Ganendren R; Widmer F; Singhal V; Wilson C; Sorrell T; Wright L
    Antimicrob Agents Chemother; 2004 May; 48(5):1561-9. PubMed ID: 15105106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species.
    Zhanel GG; Karlowsky JA; Harding GA; Balko TV; Zelenitsky SA; Friesen M; Kabani A; Turik M; Hoban DJ
    Antimicrob Agents Chemother; 1997 Apr; 41(4):863-5. PubMed ID: 9087508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and
    Miao Y; Tenor JL; Toffaletti DL; Maskarinec SA; Liu J; Lee RE; Perfect JR; Brennan RG
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.
    Wong SS; Kao RY; Yuen KY; Wang Y; Yang D; Samaranayake LP; Seneviratne CJ
    PLoS One; 2014; 9(1):e85836. PubMed ID: 24465737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Unique Dual-Readout High-Throughput Screening Assay To Identify Antifungal Compounds with Aspergillus fumigatus.
    Beattie SR; Krysan DJ
    mSphere; 2021 Aug; 6(4):e0053921. PubMed ID: 34406854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
    Hirai G; Sodeoka M
    Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous in vitro assay of the first four enzymes in the fungal aspartate pathway identifies a new class of aspartate kinase inhibitor.
    Bareich DC; Nazi I; Wright GD
    Chem Biol; 2003 Oct; 10(10):967-73. PubMed ID: 14583263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.